Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization

Mucosal Immunology

Volumn 8, Issue 1, 2015, Pages 152-160

  Nakanishi, Y ^a,b   Sato, T ^a,b   Ohteki, T ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHEMOKINE RECEPTOR CCR2; COLISTIN; INTERLEUKIN 6; METRONIDAZOLE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; NEOMYCIN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; CCR2 PROTEIN, MOUSE; DEXTRAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMMENSAL; CONTROLLED STUDY; CYTOKINE RELEASE; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE SEVERITY; DOWN REGULATION; GRAM POSITIVE BACTERIUM; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACHNOSPIRACEAE; MACROPHAGE; MACROPHAGE MIGRATION; MONOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CHEMICALLY INDUCED; COLITIS; COLON; DISEASE MODEL; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPITHELIAL CELLS; GRAM-POSITIVE BACTERIA; HUMANS; INFLAMMATORY BOWEL DISEASES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; RECEPTORS, CCR2; TUMOR NECROSIS FACTOR-ALPHA; VANCOMYCIN;

EID: 84927584876     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.53     Document Type: Article

References (40)

1. Hooper, L. V., Midtvedt, T. & Gordon, J. I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283-307 (2002)
2. Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323 (2009)
3. Honda, K. & Littman, D. R. The microbiome in infectious disease and inflammation. Annu. Rev. Nutr. 30, 759-795 (2012)
4. Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236 (2013)
5. Sartor, R. B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577-594 (2008)
6. Ubeda, C. & Pamer, E. G. Antibiotics, microbiota, and immune defense. Trends Immunol. 33, 459-466 (2012)
7. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010)
8. Lepage, P. et al. A metagenomic insight into our gut'smicrobiome. Gut 62, 146-165 (2013)
9. Eckburg,R. B. et al. Diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005)
10. Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070-11075 (2005)
11. Ley, R. E., Peterson, D. A. & Gordon, J. I. Ecological and evolutionary forces shapingmicrobial diversity in the human intestine. Cell 124, 837-848 (2006)
12. Tap, J. et al. Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 11, 2574-2584 (2009)
13. Arumugam, M. et al. Enterotype of the human gut microbiome. Nature 473, 174-180 (2011)
14. Garrett, W. S. et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33-45 (2007)
15. Bloom, S. M. et al. Commensal Bacteroides species induce colitis in hostgenotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9, 390-403 (2011)
16. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011)
17. Varol, C. et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31, 502-512 (2009)
18. Zigmond, E. et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37, 1076-1090 (2012)
19. Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507-510 (2008)
20. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011)
21. Ubeda, C. et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120, 4332-4341 (2010)
22. Ayres, J. S., Trinidad, N. J. & Vance, R. E. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat. Med. 18, 799-806 (2012)
23. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8, 411-420 (2008)
24. Mizushima, T. et al. Inhibition of epithelial cell death by Bcl-2 improved chronic colitis in IL-10 KO mice. Am. J. Pathol. 183, 1936-1944 (2013)
25. Sellon, R. K. et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 66, 5224-5231 (1998)
26. Duck, L. W. et al. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm. Bowel Dis. 13, 1191-1201 (2007)
27. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001)
28. Bannon, C., Davies, P. J., Collett, A. &Warhurst, G. Potentiation of flagellin responses in gut epithelial cells by interferon-gamma is associated with STAT-independent regulation of MyD88 expression. Biochem. J. 423, 119-128 (2009)
29. Winter, S. E. et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711 (2013)
30. Seksik, P. et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237-242 (2003)
31. Frank, D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA 104, 13780-137805 (2007)
32. Triantafillidis, J. K., Merikas, E. & Georgopoulos, F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des. Devel. Ther. 5, 185-210 (2011)
33. Zaki, M. H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391 (2010)
34. Hoshi, N. et al. MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice. Nat. Commun. 3, 1120 (2012)
35. Araki, A. et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 1, 16-23 (2005)
36. Nakanishi, Y., Lu, B., Gerard, C. & Iwasaki, A. CD8() T lymphocyte mobilization to virus-infected tissue requires CD4() T-cell help. Nature 462, 510-513 (2009)
37. Furet, J. P. et al. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol. Ecol. 68, 351-362 (2009)
38. Reeves, A. E., Koenigsknecht,M. J., Bergin, I. L. & Young, V. B. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun. 11, 3786-3794 (2012)
39. Kim, S. W. et al. Robustness of gutmicrobiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res. 20, 241-253 (2013)
40. Meyer, F. et al. The metagenomics RASTserver-a public resource for the automatic phylogenetic and functional analysis of megagenomes. BMC Bioinformatics 9, 386 (2008).